Skip to content
StockMarketAgent
Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

WSE/SPH stock hub

WSE/SPH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

WSE/SPHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.1B
Warsaw Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
WSE/SPH
In the news

Latest news · WSE/SPH

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.9P50 16.8P75 19.7
Trailing P/E14.4
P25 15.2P50 20.9P75 63
ROE15.5
P25 -39.9P50 -16.3P75 7.2
ROIC7.8
P25 -44.1P50 -13.4P75 4.6
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All WSE/SPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
228
Groups with data
11
Currency
BGN
Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Bulgaria
Country code
PL
Employees
5,932
Employees Change
306%
Employees Change Percent
5.47
Enterprise value
PLN 5.4B
Exchange
Warsaw Stock Exchange
Financial currency
BGN
First seen
2026-05-10
Industry
Medical Distribution
Isin
BG11SOSOBT18
Last refreshed
2026-05-10
Market cap
PLN 4.1B
Price
PLN 8.04
Price currency
PLN
Rev Per Employee
957,880.73x
Sector
Healthcare
Sic
2834
Symbol
wse/SPH
Website
https://www.sopharmagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
6.95%
EV Earnings
18.69x
EV/EBIT
14.36x
EV/EBITDA
10.05x
EV/FCF
-94.34x
EV/Sales
0.94x
FCF yield
-1.38%
P/B ratio
1.96x
P/E ratio
14.39x
P/S ratio
0.73x
PE Ratio10 Y
10.54x
PE Ratio3 Y
10.73x
PE Ratio5 Y
9.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
5.12%
EBITDA Margin
7.81%
Gross margin
23.75%
Gross Profit
PLN 1.3B
Gross Profit Growth
35.28%
Gross Profit Growth Q
42.72%
Gross Profit Growth3 Y
19.6%
Gross Profit Growth5 Y
14.68%
Net Income
PLN 288.2M
Net Income Growth
74.97%
Net Income Growth Q
91.66%
Net Income Growth Quarters
4%
Net Income Growth Years
1%
Net Income Growth3 Y
23.36%
Net Income Growth5 Y
34.97%
Pretax Margin
5.97%
Profit Margin
5.07%
Profit Per Employee
PLN 48,581
Profitable Years
15
ROA
4.35
Roa5y
3.81
ROCE
10.89
ROE
15.52
Roe5y
13.05
ROIC
7.82
Roic5y
7.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr10y
19.41%
Cagr1y
96.69%
Cagr3y
32.15%
Cagr5y
33.88%
Div CAGR10
21.34%
Div CAGR3
-7.22%
Div CAGR5
34.1%
EPS Growth
154
EPS Growth Q
33.29
EPS Growth Years
0
EPS Growth3 Y
27.03
EPS Growth5 Y
37.58
FCF Growth Q
-4.86%
OCF Growth
-75.82%
OCF Growth Q
-0.13%
OCF Growth10 Y
-12.09%
OCF Growth3 Y
-44.77%
Revenue Growth
22.57x
Revenue Growth Q
19.04x
Revenue Growth Quarters
13x
Revenue Growth Years
14x
Revenue Growth3 Y
16.35x
Revenue Growth5 Y
12.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
PLN 1.36
Assets
PLN 4.5B
Cash
PLN 154.5M
Current Assets
PLN 2.4B
Current Liabilities
PLN 1.8B
Debt
PLN 1.3B
Debt EBITDA
PLN 2.93
Debt Equity
PLN 0.62
Debt FCF
PLN -23.17
Equity
PLN 2.1B
Interest Coverage
6.27
Liabilities
PLN 2.4B
Long Term Assets
PLN 2.1B
Long Term Liabilities
PLN 548.1M
Net Cash
PLN -1.2B
Net Cash By Market Cap
PLN -28.17
Net Debt EBITDA
PLN 2.63
Net Debt Equity
PLN 0.55
Tangible Book Value
PLN 1.5B
Tangible Book Value Per Share
PLN 2.86
WACC
4.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.3
Inventory Turnover
4.19
Net Working Capital
PLN 1.2B
Quick ratio
0.63
Working Capital
PLN 538.6M
Working Capital Turnover
PLN 34.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
30.63%
Dividend Growth
200.38%
Dividend Growth Years
1%
Dividend per share
PLN 0.36
Dividend Years
3
Dividend Yield
4.52%
Ex Div Date
2025-12-18
Last Dividend
PLN 0.19
Payout Frequency
Semi-Annual
Payout Ratio
10.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
489.01%
1Y total return
96.6%
200-day SMA
5.6
3Y total return
130.85%
50-day SMA
7.88
50-day SMA vs 200-day SMA
50over200
5Y total return
330.07%
All Time High
16
All Time High Change
-49.75%
All Time High Date
2025-07-10
All Time Low
0.89
All Time Low Change
800.44%
All Time Low Date
2013-04-30
ATR
0.53
Beta
0.07
Ch YTD
-36.94
High
8.04
High52
16
High52 Date
2025-07-10
High52ch
-49.75%
Low
8
Low52
4
Low52 Date
2025-05-07
Low52ch
101%
Ma50ch
2.07%
Price vs 200-day SMA
43.57%
RSI
55.02
RSI Monthly
59.77
RSI Weekly
54.76
Sharpe ratio
0.8x
Sortino ratio
3.72
Total Return
35.15%
Tr YTD
-35.99
Tr1m
7.49%
Tr1w
12.92%
Tr3m
-35.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
PLN 291.1M
Operating Income Growth
70.95
Operating Income Growth Q
130.8
Operating Income Growth3 Y
16.24
Operating Income Growth5 Y
25.48
Operating margin
5.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
181,489,174%
Net Borrowing
195,434,797.6
Shares Insiders
9.94%
Shares Institutions
0.29%
Shares Qo Q
41.39%
Shares Yo Y
-30.63%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
PLN -57.1M
Average Volume
569x
Bv Per Share
3.91
CAPEX
PLN -97.1M
Ch10y
302.6
Ch1m
7.49
Ch1w
12.92
Ch1y
91.43
Ch3m
-36.94
Ch3y
77.37
Ch5y
230.5
Ch6m
-36.94
Change
0%
Change From Open
0.5
Close
8.04
Days Gap
-0.5
Depreciation Amortization
153,342,982.1
Dollar Volume
15,115.2
Earnings Date
2026-04-30
EBIT
PLN 291.1M
EBITDA
PLN 443.8M
EPS
PLN 0.84
F Score
6
FCF
PLN -57.1M
FCF EV Yield
-1.06x
Financing CF
298,011,960
Fiscal Year End
December
Founded
1,933
Goodwill
11,882,938.3
Graham Number
7.18524
Graham Upside
-10.63
Income Tax
PLN 33.8M
Investing CF
-260,405,422
Is Primary Listing
0
Last Earnings Date
2026-04-30
Last Report Date
2025-12-31
Last Split Date
2025-07-10
Last Split Type
Forward
Lynch Fair Value
PLN 13.97
Lynch Upside
73.7
Ma150
6
Ma150ch
34%
Ma20
7.62
Ma20ch
5.54%
Net CF
77,643,343
Next Earnings Date
2026-06-01
Open
8
P OCF Ratio
103.6
Payment Date
2026-02-02
Position In Range
100
Ppne
894,790,670.9
Price Date
2026-05-07
Price EBITDA
PLN 9.34
Ptbv Ratio
2.76
Relative Volume
3.3x
Revenue
5,682,148,520x
Tax By Revenue
0.59x
Tax Rate
9.96%
Tr6m
-35.99%
Volume
1,880
Z Score
2.53
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

WSE/SPH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+4.5%
$0.36 annual per share
Payout ratio
+10.2%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+34.1%
1 consecutive years of growth
Total shareholder yield
+35.1%
Next ex-dividend date: 2025-12-18
Performance

WSE/SPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+96.6%
S&P 500 1Y: n/a
3Y total return
+130.8%
S&P 500 3Y: n/a
5Y total return
+330.1%
S&P 500 5Y: n/a
10Y total return
+489.0%
S&P 500 10Y: n/a
Ownership

Who owns WSE/SPH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.3%
Share of float held by funds and institutions
Insider ownership
+9.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-30.6%
Negative means the company is buying back shares.
Technical

WSE/SPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.0
Neutral momentum band
Price vs 200-day MA
+43.6%
50/200-day relationship not available
Beta (5Y)
0.07
Less volatile than the market
Sharpe ratio
0.80
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About WSE/SPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/SPH stock rating?

wse/SPH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/SPH analysis?

The full report lives at /stocks/wse/SPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/SPH?

The latest report frames wse/SPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/SPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.